
GSK signs agreement to streamline clinical trials
GSK has announced an agreement with Protas to streamline clinical trials of vaccines and therapeutics. The three-year agreement sets out to build on an existing two-year relationship and will broaden the scope of work across numerous projects. This includes Phase II and III trials within GSK’s respiratory,… Read More

